RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LLBT) announced today that the recent capital restructuring has positioned the Company to continue the development of its First Warning System™, which is designed to assist in the early detection of breast cancer.
